The utility of two daytime icodextrin exchanges to reduce dextrose exposure in automated peritoneal dialysis patients: A pilot study of nine patients

Blood Purification

Volumn 26, Issue 3, 2008, Pages 279-283

  Gobin, Jaya ^a   Fernando, Sanjay ^a   Santacroce, Sally ^b   Finkelstein, Fredric O ^a,b,c,d  

^a HOSPITAL OF SAINT RAPHAEL   (United States)

^b Renal Research Institute   (United States)

^c YALE UNIVERSITY   (United States)

^d NONE   (United States)

Author keywords

Automated peritoneal dialysis; Dextrose; Icodextrin

Indexed keywords

GLUCOSE; ICODEXTRIN; SODIUM;

ADULT; AGED; ARTICLE; AUTOMATED PERITONEAL DIALYSIS; CLINICAL ARTICLE; COHORT ANALYSIS; FEMALE; HUMAN; MALE; PERITONEAL DIALYSIS; PERITONEUM; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SAFETY; SODIUM BLOOD LEVEL; ULTRAFILTRATION;

ADULT; AGED; BIOLOGICAL TRANSPORT; BODY WEIGHT; DIABETIC NEPHROPATHIES; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLUCANS; GLUCOSE; HEMODIALYSIS SOLUTIONS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PROSPECTIVE STUDIES; SODIUM;

EID: 44349135131     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000126924     Document Type: Article

References (16)

1. Krediet RT: The peritoneal membrane in chronic peritoneal dialysis. Kidney Int 1999;55:341-356.
2. Witowski J, Korybalska K, Wisniewska AJ, Breborowicz A, Gahl GM, Frei U, Passick-Deetjen J, Jorre A: Effect of glucose degradation products on human peritoneal mesothelial cell function. J Am Soc Nephrol 2000;11:729-739.
3. Wolfson M, Jones MR: Nutrition impact of peritoneal dialysis solutions. Miner Electrolyte Metab 1999;25:333-336.
4. Brulez HF, van Guldener C, Donker AJ, ter Wee PM: The impact of amino acid-based peritoneal dialysis fluid on plasma total homocysteine levels, lipid profile and body fat mass. Nephrol Dial Transplant 1999;14:154-159.
5. Holmes CJ, Shockley TR: Strategies to reduce glucose exposure in peritoneal dialysis patients. Perit Dial Int 2000;20(suppl):S37-S41.
6. Krediet RT: Glucose polymer solution (Icodextrin) is ideal for high peritoneal transporter. PD Today 1998;4:14-15.
7. Finkelstein F, Healy H, Abu-Alfa A, Ahmad S, Brown F, Gehr T, Nash K, Sorkin M, Mujais S: Superiority of icodextrin compared with 4.25% dextrose for peritoneal ultrafiltration. J Am Soc Nephrol 2005;16:546-554.
8. Plum J, Gentile S, Verger C, Brunkhorst R: Efficacy and safety of 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis. Am J Kidney Dis 2002;39:862-871.
9. Mooraki A, Kliger AS, Gorban-Brennan N, et al: Weekly KT/V urea and selected outcome criteria in 56 randomly selected CAPD patients. Adv Perit Dial 1993;9:92-96.
10. Moberly JB, Mujais S, Gehr T, Hamburger R, et al: Pharmacokinetics of icodextrin in peritoneal dialysis patients. Kidney Int Suppl 2002;62:S23-S33.
11. Cooker LA, Holmes CJ, Hoff C: Biocompatibility of icodextrin. Kidney Int 2002;62(suppl 81):S534-S545.
12. Frampton JE, Plosker GL: Icodextrin: its use in peritoneal dialysis. Drugs 2003;63:2079-2105.
13. Wolfson M, Ogrinc F, Mujais S: Review of clinical trial experience with icodextrin. Kidney Int 2002;62(suppl 8):S46-S52.
14. Gokal R, Moberley J, Lindholm B, Mujais S: Metabolic and laboratory effects of icodextrin. Kidney Int 2002;62(suppl 81):S62-S71.
15. Posthuma N, ter Wee PM, Donker AJ, Oe PL: Serum dissacharides and osmolality in CCPD patients using icodextrin or glucose as daytime dwell. Perit Dial Int 1997;17:602-607.
16. Divino FJC: Allergic reactions to icodextrin in patients with renal failure. Lancet 2000;355:1364-1365.